vs
Healthpeak Properties（DOC）与Guardian Pharmacy Services, Inc.（GRDN）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是Guardian Pharmacy Services, Inc.的1.8倍（$719.4M vs $397.6M），Healthpeak Properties净利率更高（73.2% vs 5.3%，领先67.9%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CVS药房是美国零售企业，为CVS健康旗下子公司，总部位于罗德岛州文索基特，前身为Consumer Value Stores，1963年在马萨诸塞州洛厄尔成立，是美国知名的零售药房服务提供商，在药品零售、健康服务领域拥有广泛的业务布局。
DOC vs GRDN — 直观对比
营收规模更大
DOC
是对方的1.8倍
$397.6M
净利率更高
DOC
高出67.9%
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $397.6M |
| 净利润 | $114.0M | $20.9M |
| 毛利率 | — | 21.5% |
| 营业利润率 | 17.4% | 7.7% |
| 净利率 | 73.2% | 5.3% |
| 营收同比 | 3.1% | — |
| 净利润同比 | 2406.4% | — |
| 每股收益（稀释后） | $0.16 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCGRDN
| Q4 25 | $719.4M | $397.6M | ||
| Q3 25 | $705.9M | $377.4M | ||
| Q2 25 | $694.3M | $344.3M | ||
| Q1 25 | $702.9M | $329.3M | ||
| Q4 24 | $698.0M | — | ||
| Q3 24 | $700.4M | $314.4M | ||
| Q2 24 | $695.5M | — | ||
| Q1 24 | $606.6M | — |
净利润DOCGRDN
| Q4 25 | $114.0M | $20.9M | ||
| Q3 25 | $-117.1M | $9.8M | ||
| Q2 25 | $31.7M | $9.0M | ||
| Q1 25 | $42.8M | $9.4M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $85.9M | $-122.0M | ||
| Q2 24 | $146.0M | — | ||
| Q1 24 | $6.7M | — |
毛利率DOCGRDN
| Q4 25 | — | 21.5% | ||
| Q3 25 | 58.6% | 19.8% | ||
| Q2 25 | 60.2% | 19.8% | ||
| Q1 25 | 61.1% | 19.5% | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | 19.4% | ||
| Q2 24 | 60.6% | — | ||
| Q1 24 | 59.8% | — |
营业利润率DOCGRDN
| Q4 25 | 17.4% | 7.7% | ||
| Q3 25 | 9.2% | 4.3% | ||
| Q2 25 | 5.7% | 3.7% | ||
| Q1 25 | 7.7% | 3.9% | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | 14.1% | -33.3% | ||
| Q2 24 | 22.3% | — | ||
| Q1 24 | 3.7% | — |
净利率DOCGRDN
| Q4 25 | 73.2% | 5.3% | ||
| Q3 25 | -16.6% | 2.6% | ||
| Q2 25 | 4.6% | 2.6% | ||
| Q1 25 | 6.1% | 2.9% | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 12.3% | -38.8% | ||
| Q2 24 | 21.0% | — | ||
| Q1 24 | 1.1% | — |
每股收益（稀释后）DOCGRDN
| Q4 25 | $0.16 | — | ||
| Q3 25 | $-0.17 | — | ||
| Q2 25 | $0.05 | — | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $0.21 | — | ||
| Q1 24 | $0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $65.6M |
| 总债务越低越好 | $9.8B | $0 |
| 股东权益账面价值 | $7.5B | $217.9M |
| 总资产 | $20.3B | $412.7M |
| 负债/权益比越低杠杆越低 | 1.31× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资DOCGRDN
| Q4 25 | $467.5M | $65.6M | ||
| Q3 25 | $91.0M | $36.5M | ||
| Q2 25 | $89.4M | $18.8M | ||
| Q1 25 | $70.6M | $14.0M | ||
| Q4 24 | $119.8M | — | ||
| Q3 24 | $180.4M | $37.2M | ||
| Q2 24 | $106.9M | — | ||
| Q1 24 | $101.8M | — |
总债务DOCGRDN
| Q4 25 | $9.8B | $0 | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | $34.3M | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCGRDN
| Q4 25 | $7.5B | $217.9M | ||
| Q3 25 | $7.6B | $195.5M | ||
| Q2 25 | $7.9B | $179.7M | ||
| Q1 25 | $8.2B | $163.2M | ||
| Q4 24 | $8.4B | — | ||
| Q3 24 | $8.6B | $133.9M | ||
| Q2 24 | $8.8B | — | ||
| Q1 24 | $8.9B | — |
总资产DOCGRDN
| Q4 25 | $20.3B | $412.7M | ||
| Q3 25 | $19.6B | $390.0M | ||
| Q2 25 | $19.8B | $356.3M | ||
| Q1 25 | $19.8B | $334.0M | ||
| Q4 24 | $19.9B | — | ||
| Q3 24 | $20.0B | $348.0M | ||
| Q2 24 | $20.2B | — | ||
| Q1 24 | $20.5B | — |
负债/权益比DOCGRDN
| Q4 25 | 1.31× | 0.00× | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | 0.26× | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $34.6M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | — |
| 自由现金流率自由现金流/营收 | 49.6% | — |
| 资本支出强度资本支出/营收 | 124.4% | — |
| 现金转化率经营现金流/净利润 | 10.99× | 1.65× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCGRDN
| Q4 25 | $1.3B | $34.6M | ||
| Q3 25 | $315.0M | $28.2M | ||
| Q2 25 | $363.5M | $19.9M | ||
| Q1 25 | $279.4M | $17.6M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $318.2M | — | ||
| Q2 24 | $316.2M | — | ||
| Q1 24 | $152.6M | — |
自由现金流DOCGRDN
| Q4 25 | $357.0M | — | ||
| Q3 25 | — | $24.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $333.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率DOCGRDN
| Q4 25 | 49.6% | — | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DOCGRDN
| Q4 25 | 124.4% | — | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 105.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率DOCGRDN
| Q4 25 | 10.99× | 1.65× | ||
| Q3 25 | — | 2.87× | ||
| Q2 25 | 11.48× | 2.21× | ||
| Q1 25 | 6.52× | 1.86× | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | 22.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
